Stock 6926 SHINE-ON BIOMEDICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shine-On BioMedical Co.,Ltd.

Equities

6926

TW0006926009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 25/06/2024 am IST 		5-day change 1st Jan Change
66.6 TWD +0.60% Intraday chart for Shine-On BioMedical Co.,Ltd. +2.15% -4.03%
19/04 Shine-On BioMedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Cytoengine Co., Ltd. and Shine-On BioMedical Co., Ltd. Enters into an Exclusive Optional Licensing Agreement for an Exosome Technology CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 - 3,456
Enterprise Value (EV) 1 - 2,320
P/E ratio -147 x -92.5 x
Yield - -
Capitalization / Revenue - 36,28,85,342 x
EV / Revenue - 24,35,56,699 x
EV / EBITDA - -37.4 x
EV / FCF - -7,29,37,585 x
FCF Yield - -0%
Price to Book 2.68 x 3.04 x
Nbr of stocks (in thousands) - 49,800
Reference price 2 63.20 69.40
Announcement Date 21/04/23 19/04/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - 9.524
EBITDA 1 -11.22 -18.07 -61.97
EBIT 1 -11.5 -18.61 -62.68
Operating Margin - - -658.16%
Earnings before Tax (EBT) 1 -11.24 -21.82 -34.94
Net income 1 -11.24 -19.54 -37.16
Net margin - - -390.22%
EPS 2 -0.6133 -0.4304 -0.7500
Free Cash Flow - -14.29 -31.8
FCF margin - - -333.92%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 21/04/23 21/04/23 19/04/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - - -
Net Cash position 1 904 1,165 1,136
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -14.3 -31.8
ROE (net income / shareholders' equity) - -1.88% -3.22%
ROA (Net income/ Total Assets) - -1.11% -3.35%
Assets 1 - 1,755 1,109
Book Value Per Share 2 49.10 23.60 22.80
Cash Flow per Share 2 44.70 7.490 2.050
Capex 1 2.25 0.48 0.07
Capex / Sales - - 0.71%
Announcement Date 21/04/23 21/04/23 19/04/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SHINE-ON BIOMEDICAL CO.,LTD. Stock Shine-On BioMedical Co.,Ltd.
-4.03% 10Cr
MODERNA, INC. Stock Moderna, Inc.
+38.36% 5.25TCr
LONZA GROUP AG Stock Lonza Group AG
+36.73% 3.93TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.63% 3.9TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+25.46% 2.82TCr
CELLTRION, INC. Stock Celltrion, Inc.
-11.17% 2.66TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.44% 2.62TCr
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+45.09% 1.42TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.93% 1.26TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-5.30% 1.17TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6926 Stock
  4. Financials Shine-On BioMedical Co.,Ltd.